Biotechnology stocks have been back in the spotlight since the beginning of the year. Successes in research and market approvals for new drugs could provide fresh impetus. Is the sector worth a look now?
Artikel zu “Gilead Sciences”
Despite correction: long-term upward trend of biotech companies intact
Biotechnology shares have seen better times. Despite the most recent corrections, hopes for growth in the biotechnology sector remain very high. We spoke to Harald Kober, fund manager of ERSTE STOCK BIOTEC, about the latest developments.
Gesundheit!
The desire for health is a constant companion in social life. In a developed country with a well-developed health and insurance system, it may be forgotten, but health is a highly unevenly distributed commodity.